Results 41 to 50 of about 9,727 (175)

Adherence and Outcomes with Urate-Lowering Therapy: A Site-Randomized Trial [PDF]

The American Journal of Medicine, 2019
The purpose of this study was to test a pharmacist-led intervention to improve gout treatment adherence and outcomes.We conducted a site-randomized trial (n=1463 patients) comparing a 1-year, pharmacist-led intervention to usual care in patients with gout initiating allopurinol.
Ted R. Mikuls, T. Craig Cheetham, Gerald D. Levy, Nazia Rashid, Artak Kerimian, Kimberly J. Low, Brian W. Coburn, David T. Redden, Kenneth G. Saag, P. Jeffrey Foster, Lang Chen, Jeffrey R. Curtis   +11 more
openaire   +2 more sources

Farnesoid X receptor prevents hyperuricemia via activating ATP‐binding cassette subfamily G member 2

Rheumatology &Autoimmunity, EarlyView.
Farnesoid X receptor (FXR) activation reduces serum uric acid levels by upregulating the intestinal urate transporter ATP‐binding cassette subfamily G member 2 (ABCG2). These findings uncover a novel metabolic pathway for urate excretion and suggest that FXR agonists (e.g., obeticholic acid), represent a promising therapeutic strategy for the treatment
Rui Li, Guo Tang, Ye Yu, Guang‐Liang Chen, Liangjing Lu, Juan Wang   +5 more
wiley   +1 more source

HEART FAILURE AND URATE-LOWERING THERAPY: CLINICAL ASPECTS

University therapeutic journal, 2022
Сердечная недостаточность (СН) - широко распространенное заболевание, представляющее глобальную проблему. В этой связи актуальны исследования, направленные на поиск подходов, снижающих риски неблагоприятных событий, ассоциированных с СН. Эксперты солидарны в том, что существует острая потребность в наличии доступных в рутинной клинической практике ...
openaire   +1 more source

Urate Handling in the Human Body [PDF]

, 2016
Elevated serum urate concentration is the primary cause of gout. Understanding the processes that affect serum urate concentration is important for understanding the etiology of gout and thereby understanding treatment. Urate handing in the human body is
David Hyndman, Jeffrey N. Miner, Sha Liu
core   +1 more source

Use of Glucagon‐Like Peptide‐1 Receptor Agonists and Risk of Parkinson's Disease: Scandinavian Cohort Study

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims To investigate the association between use of GLP‐1 receptor agonists and incident Parkinson's disease. Material and Methods Cohort study using data from nationwide registers in Denmark, Norway and Sweden and an active‐comparator, new‐user design.
Arvid Engström, Henrik Svanström, Anders Hviid, Björn Eliasson, Soffia Gudbjörnsdottir, Viktor Wintzell, Kristian Hveem, Christian Jonasson, Mads Melbye, Peter Ueda, Björn Pasternak   +10 more
wiley   +1 more source

Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement [PDF]

, 2016
Background: Recently published guidelines on the medical management of renal stone disease did not address relevant topics in the field of idiopathic calcium nephrolithiasis, which are important also for clinical research.
Bartoletti, R., Buchholz, N., Buchholz, N.N.-P. (Noor), Bushinsky, D., Bushinsky, D. (David), Capasso, G.B., Cicerello, E., Coe, F., Coe, F. (Fredric), Croppi, E. (Emanuele), Cupisti, A., Curhan, G.C., Curhan, G.C. (Gary C.), Desai, J., Fabris, A., Ferraro, P.M., Ferraro, P.M. (Pietro Manuel), Fuster, D., Fuster, D. (Daniel), Gambaro, G., Gambaro, G. (Giovanni), Goldfarb, D.S., Goldfarb, D.S. (David S.), Heilberg, I.P., Heilberg, I.P. (Ita Pfeferman), Hess, B., Hess, B. (Bernhard), Jaeger, P. (Ph), Kirkali, Z. (Ziya), Kok, D.J. (Dirk), Letavernier, E., Lieske, J., Lieske, J. (John), Lingeman, J., Lingeman, J. (James), Marangella, M., Marangella, M. (Martino), Mazzaferro, S., Milliner, D., Milliner, D. (Dawn), Moe, O., Moe, O. (Orson), Nouvenne, A., Preminger, G.M., Preminger, G.M. (Glen M.), Prie, D., Reis Santos, J., Reis Santos, J.M. (Jose’ Manuel), Rendina, D., Sakhaee, K. (Khashayar), Sarica, K., Sarica, K. (Kemal), Siener, R., Siener, R. (Roswitha), Soldati, L., Strazzullo, P., Strazzullo, P. (Pasquale), Tasca, A., Trinchieri, A., Vezzoli, G., Vitale, C., Williams, J.C., Williams, J.C. (James C.), Worcester, E., Worcester, E. (Elen), Wu, W.   +65 more
core   +3 more sources

Exploring a Subpopulation of MASLD Associated With New Onset of CKD Using Supervised Clustering Techniques

Hepatology Research, EarlyView.
The supervised clustering of metabolic dysfunction‐associated steatotic liver disease (MASLD) using a SHapley Additive exPlanations (SHAP)‐converted matrix reveals distinct subpopulations that improved risk stratification for new onset of chronic kidney disease (CKD).
Itaru Hosaka, Marenao Tanaka, Tatsuya Sato, Yukinori Akiyama, Keitaro Nishizawa, Rie Matsumori, Hiroki Aida, Wataru Kawaharata, Kei Nakata, Koki Abe, Toru Suzuki, Hidemichi Kouzu, Naoya Yama, Nagisa Hanawa, Masato Furuhashi   +14 more
wiley   +1 more source

Gout and risk of chronic kidney disease and nephrolithiasis meta-analysis of observational studies [PDF]

, 2015
ntroduction To determine the prevalence of chronic kidney disease and nephrolithiasis in people with gout, and the association between gout and prevalent or incident chronic kidney disease and nephrolithiasis.
Belcher, J, Mallen, CD, Roddy, E
core   +2 more sources

Maternal nutrition as a key determinant of placental and developing blood–brain barrier xenobiotic protective functions

The Journal of Physiology, EarlyView.
Abstract figure legend Suboptimal maternal nutrition alters placental and developing blood–brain barrier (BBB) protective function and is associated with increased fetal brain vulnerability. In the placenta, nutritional adversity may reduce the exchange surface area and promote meta‐inflammation, compromising barrier efficiency in a model‐ and context ...
Kristin L. Connor, Nycolle I. S. Souza, Bruno G. Anjos, Stephen G. Matthews, Enrrico Bloise   +4 more
wiley   +1 more source

Advances in Avian Diagnostic Pathology: Current Trends, Challenges and Future Directions: A Review

Veterinary Medicine and Science, Volume 12, Issue 3, May 2026.
Advances in avian diagnostic pathology integrate histopathology, immunohistochemistry, molecular diagnostics and digital pathology to enhance the detection and management of poultry diseases. Emerging tools, including machine learning and artificial intelligence, further improve diagnostic accuracy, disease surveillance and outbreak prediction.
Gebyaw Menge Getnet, Mengesha Ayehu Getnet, Ayenalem Shibabaw Atenaf   +2 more
wiley   +1 more source